Vanguard Group Inc Igm Biosciences, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 890,200 shares of IGMS stock, worth $6.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

890,200

Previous 878,621 1.32%

Holding current value

$6.14 Million

Previous $6.04 Million 143.92%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.28 - $17.68 $72,716 - $204,716	11,579 Added 1.32%	890,200 $14.7 Million
Q2 2024 Aug 13, 2024	BUY	$6.51 - $11.47 $162,509 - $286,325	24,963 Added 2.92%	878,621 $6.04 Million
Q1 2024 May 10, 2024	SELL	$8.68 - $17.36 $377,501 - $755,003	-43,491 Reduced 4.85%	853,658 $8.24 Million
Q4 2023 Feb 14, 2024	SELL	$3.94 - $8.79 $11,260 - $25,121	-2,858 Reduced 0.32%	897,149 $7.46 Million
Q3 2023 Nov 14, 2023	BUY	$6.66 - $10.64 $1.35 Million - $2.16 Million	202,719 Added 29.07%	900,007 $7.52 Million
Q2 2023 Aug 14, 2023	BUY	$8.86 - $14.0 $1.04 Million - $1.64 Million	116,926 Added 20.15%	697,288 $6.44 Million
Q1 2023 May 15, 2023	BUY	$13.74 - $25.76 $43,899 - $82,303	3,195 Added 0.55%	580,362 $7.97 Million
Q4 2022 Feb 10, 2023	BUY	$15.45 - $26.02 $883,585 - $1.49 Million	57,190 Added 11.0%	577,167 $9.82 Million
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $139,458 - $244,278	9,044 Added 1.77%	519,977 $11.8 Million
Q2 2022 Aug 12, 2022	SELL	$13.27 - $25.5 $4.24 Million - $8.14 Million	-319,144 Reduced 38.45%	510,933 $9.21 Million
Q1 2022 May 13, 2022	BUY	$13.42 - $29.73 $5.57 Million - $12.3 Million	415,028 Added 99.99%	830,077 $22.2 Million
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $68,699 - $165,311	2,490 Added 0.6%	415,049 $12.2 Million
Q3 2021 Nov 12, 2021	BUY	$65.76 - $90.65 $181,234 - $249,831	2,756 Added 0.67%	412,559 $27.1 Million
Q2 2021 Aug 13, 2021	BUY	$57.98 - $96.6 $23.8 Million - $39.6 Million	409,803 New	409,803 $34.1 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $200M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Igm Biosciences, Inc. Transaction History